Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Biography

Meet the Editorial Board Member

Author(s): Luisa Fiandra

Volume 23, Issue 12, 2022

Published on: 10 August, 2022

Page: [1415 - 1415] Pages: 1

DOI: 10.2174/138920102312220810155903

conference banner
Next »
[1]
Bellini, M.; Riva, B.; Tinelli, V.; Rizzuto, M.A.; Salvioni, L.; Colombo, M.; Mingozzi, F.; Visioli, A.; Marongiu, L.; Frascotti, G.; Christodoulou, M.S.; Passarella, D.; Prosperi, D.; Fiandra, L. Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer. Small, 2020, 28, e2001450.
[2]
Das, P.; Fatehbasharzad, P.; Colombo, M.; Fiandra, L.; Prosperi, D. Multifunctional Magnetic Gold Nanomaterials for Cancer. Trends Biotechnol., 2019, 37(9), 995-1010.
[3]
Colombo, M.; Rizzuto, M.; Pandolfi, L.; Pacini, C.; Bonizzi, A.; Truffi, M.; Monieri, M. Catrambone, Francesco, Fiandra L, Corsi F, Prosperi D, Mazzucchelli S. Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer. Bioconjug. Chem., 2018, 29(11), 3817-3832.
[4]
Fiandra, L.; Capetti, A.; Sorrentino, L.; Corsi, F. Nanoformulated antiretrovirals for penetration of the central nervous system: state of the art. J. Neuroimmune Pharmacol., 2017, 12(1), 17-30.
[5]
Mazzucchelli, S.; Bellini, M.; Fiandra, L.; Truffi, M.; Rizzuto, M.A.; Sorrentino, L.; Longhi, E.; Nebuloni, M.; Prosperi, D.; Corsi, F. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity. Oncotarget, 2017, 8(5), 8383-8396.
[6]
Colombo, M.; Fiandra, L.; Alessio, G.; Mazzucchelli, S.; Nebuloni, M.; De Palma, C.; Kantner, K.; Pelaz, B.; Corsi, F.; Parak, W.J.; Prosperi, D. Less Is More - How in Vivo Tumor Homing and Localization of Colloidal Nanoparticles Depends on the Number of Attached Antibodies. Nature Communications. Nat. Commun., 2016, 7, 13818.
[7]
Salvioni, L.; Fiandra, L.; Del Curto, M.; Mazzucchelli, S.; Allevi, R.; Truffi, M. Sorrentino l, Santini B, Cerea M, Plaugan L, Corsi F, Colombo M. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats. Pharmacol. Res., 2016, 110, 122-130.
[8]
Fiandra, L.; Colombo, M.; Mazzucchelli, S.; Truffi, M.; Santini, B.; Allevi, R.; Nebuloni, M.; Capetti, A.; Rizzardini, G.; Prosperi, D.; Corsi, F. Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice. Nanomedicine, 2015, 11(6), 1387-1397.
[9]
Bellini, M.; Mazzucchelli, S.; Galbiati, E.; Sommaruga, S.; Fiandra, L.; Truffi, M.; Rizzuto, M.A.; Colombo, M.; Tortora, P.; Corsi, F.; Prosperi, D. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells. J. Control. Release, 2014, 196, 184-196.
[10]
Fiandra, L.; Mazzucchelli, S.; De Palma, C.; Colombo, M.; Allevi, R.; Sommaruga, S.; Clementi, E.; Bellini, M.; Prosperi, D.; Corsi, F. Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. ACS Nano, 2013, 7, 6092-6102.
[11]
Corsi, F.; Fiandra, L.; De Palma, C.; Colombo, M.; Mazzucchelli, S.; Verderio, P.; Allevi, R.; Tosoni, A.; Nebuloni, M.; Clementi, E.; Prosperi, D. HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice. ACS Nano, 2011, 5, 6383-6393.

© 2024 Bentham Science Publishers | Privacy Policy